Recommended Pages at onclive.com
Dr. Ellis on Heterogeneity Impacting Biomarker Efficacy
onclive.com — “Dr. Matthew Ellis, from Siteman Cancer Center, on Heterogeneity Impacting Biomarker Efficacy” View full resource at onclive.com
Most Recently Shared on May 9, 2012 at 9:30 pm By:
Dr. Matthew Ellis from @SitemanCenter on Heterogeneity Impacting Biomarker Efficacy http://t.co/xiRSCLVj #OncLiveTV
Treating Patients Enrolled in Clinical Trials
onclive.com — “All oncology nurses—not just nurse researchers—will need to understand the fundamentals of clinical trials as patient access to the studies continues to expand.” View full resource at onclive.com
Most Recently Shared on May 5, 2012 at 5:29 pm By:
Treating Patients Enrolled in Clinical Trials http://t.co/td7Evcaa #ONScongress
'Episode-Based Payment' Could Rein in US Oncology Drug Costs
onclive.com — “With the recent consideration of the 2010 Affordable Care Act by the US Supreme Court, the rising costs of healthcare have appeared, once again, on our radar screens.” View full resource at onclive.com
Most Recently Shared on May 2, 2012 at 1:55 pm By:
"Episode-Based Payment" Could Rein in US Oncology Drug Costs http://t.co/lfsD7FQY #oncology
Dr. Leonard Gomella Discusses PSA Velocity
onclive.com — “Dr. Leonard Gomella, from Jefferson Kimmel Cancer Center, Discusses PSA Velocity” View full resource at onclive.com
Most Recently Shared on May 1, 2012 at 9:31 pm By:
OncLive TV: Dr. Leonard Gomella Discusses PSA Velocity http://t.co/RV8AJ4fD #prostatecancer
Challenges and Breakthroughs in Cancer Pain Management
onclive.com — “Cancer pain management has greatly improved with advances in oral and intravenous medication. However, several challenges still exist in administration.” View full resource at onclive.com
Most Recently Shared on May 1, 2012 at 8:02 pm By:
Challenges and Breakthroughs in Cancer Pain Management http://t.co/zJzE3l6O
Pass the Carrots Please
onclive.com — “Costs associated with obesity are even higher than originally thought.” View full resource at onclive.com
Most Recently Shared on May 1, 2012 at 3:37 pm By:
Great blog entry by Lisa Schulmeister, titled "Pass the Carrots Please" on the increasing obesity rates http://t.co/CcpaLlwg
?Managing Dermatologic Toxicities Associated With Targeted Therapies
onclive.com — “Many targeted therapies are associated with dermatologic side effects; the monitoring and treating of these side effects should be done on an individual patient basis.” View full resource at onclive.com
Most Recently Shared on May 1, 2012 at 2:01 pm By:
Managing Dermatologic Toxicities Associated With Targeted Therapies http://t.co/RrY8FCck
Genetic Assessment of Breast and Ovarian Cancer Risk
onclive.com — “Understanding the genetic basis of breast and ovarian cancers is essential to providing patients with effective preventive and/or management strategies that can improve outcomes.” View full resource at onclive.com
Most Recently Shared on April 30, 2012 at 9:54 pm By:
Genetic Assessment of Breast and Ovarian Cancer Risk http://t.co/4kMgyjhk
Dr. Spector on the Importance of Tumor Microenvironments
onclive.com — “Dr. Neil Spector, from Duke Cancer Institute, Emphasizes the Importance of Studying Tumor Microenvironments” View full resource at onclive.com
Most Recently Shared on April 30, 2012 at 6:57 pm By:
Dr. Neil Spector from @DukeCancer Emphasizes the Importance of Studying Tumor Microenvironments http://t.co/6MCGVSw7 #OncLiveTV
Robotic Surgery Is Useful Option for Oral Cancer
onclive.com — “Minimally invasive transoral robotic surgery, used alone or combined with adjuvant therapy, provides good functional and oncologic outcomes in patients with oropharyngeal squamous cell carcinoma.” View full resource at onclive.com
Most Recently Shared on April 30, 2012 at 5:02 pm By:
Robotic Surgery Is Useful Option for Oral Cancer http://t.co/72c8bjYn
Coronary Artery Disease May Boost Risk of Prostate Cancer
onclive.com — “Coronary artery disease and prostate cancer have been shown to share several modifiable and nonmodifiable risk factors including age, race, family history, and possibly diet.” View full resource at onclive.com
Most Recently Shared on April 30, 2012 at 1:32 pm By:
Coronary Artery Disease May Boost Risk of Prostate Cancer http://t.co/FU0AKmOk
PARP Inhibitors Intriguing Despite Research Setbacks
onclive.com — “Despite initial disappointing findings on overall survival, PARP inhibitors remains under active investigation for patients with ovarian cancer.” View full resource at onclive.com
Most Recently Shared on April 26, 2012 at 10:01 pm By:
PARP inhibitors remains under active investigation for patients with ovarian cancer http://t.co/r1vjRYRU
Dr. Zelenetz Discusses Treatment Options for DLBCL
onclive.com — “Dr. Andrew Zelenetz, from Memorial Sloan-Kettering Cancer Center, Discusses Treatment Options for DLBCL” View full resource at onclive.com
Most Recently Shared on April 26, 2012 at 7:08 pm By:
Dr. Andrew Zelenetz from @sloan_kettering Discusses Treatment Options for DLBCL http://t.co/T3z3OzLy #OncLiveTV
Collaboration Across Disciplines Driving Progress in Breast Cancer: A Conversation With Debu Tripathy, MD
onclive.com — “Debu Tripathy, MD, from the University of Southern California Norris Comprehensive Cancer Center, was one of four co-chairs of the 2012 Miami Breast Cancer Conference.” View full resource at onclive.com
Most Recently Shared on April 26, 2012 at 2:09 pm By:
Collaboration Across Disciplines Driving Progress in Breast Cancer: A Conversation With Debu Tripathy, MD http://t.co/X1mbpR0R
6-Fold Melanoma Increase Is Found Among Young Adults
onclive.com — “Cutaneous melanoma is becoming increasingly common in young adults, with an 8-fold increase among young adult females and a 4-fold increase among young adult males.” View full resource at onclive.com
Most Recently Shared on April 24, 2012 at 9:49 pm By:
Cutaneous melanoma is becoming increasingly common in young adults http://t.co/4yNLWHjc
